Zobrazeno 1 - 10
of 1 795
pro vyhledávání: '"IIb/IIIa inhibitors"'
Autor:
Jia Liao, Miaohan Qiu, Xiaojian Feng, Kui Chen, Dingbao Zhang, Yuncheng Zou, Xiaohui Zheng, Gang Zhao, Nailiang Tian, Zeqi Zheng, Xiaoping Peng, Qing Yang, Zhenyang Liang, Yi Li, Yaling Han, Gregg W. Stone
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Conflicting results comparing bivalirudin versus heparin anticoagulation in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), in part due to the confoundi
Externí odkaz:
https://doaj.org/article/0670a340ec1447df95f0979e5e05b1a7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giuseppe De Luca, Ashley Verburg, Arnoud van’t Hof, Jurrien ten Berg, Dean J. Kereiakes, Barry S. Coller, Charles Michael Gibson
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2023 (2024)
Acute myocardial infarction still represents the major cause of mortality in high-income countries. Therefore, considerable efforts have been focused on the treatment of myocardial infarctions in the acute and long-term phase, with special attention
Externí odkaz:
https://doaj.org/article/b8de5fb538254d91b06a14e94ad39289
Autor:
Jun Wang, Dongna Zou
Publikováno v:
Annals of Medicine, Vol 55, Iss 1 (2023)
AbstractTirofiban is a small non-peptide ligand-mimetic Glycoprotein (GP) IIb/IIIa inhibitor which can reversibly bind to the arginine-glycine-aspartic acid (RGD) recognition site of GP IIb/IIIa to prevent platelet aggregation. It reduces the inciden
Externí odkaz:
https://doaj.org/article/c550be573830420487663e63fda97b0b
Publikováno v:
Journal of Cardiovascular and Thoracic Research, Vol 14, Iss 3, Pp 201-204 (2022)
Glycoprotein IIb/IIIa inhibitors play a key role in the treatment of patients who have acute coronary syndromes and undergone percutaneous coronary intervention. However, its serious complication is diffused alveolar hemorrhage. A 73-year-old diabeti
Externí odkaz:
https://doaj.org/article/f40a93b1b33547ee94e0fe2682b01471
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wael Sumaya, William A.E. Parker, Heather M. Judge, Ian R. Hall, Rachel C. Orme, Zulfiquar Adam, James D. Richardson, Alexander M.K. Rothman, Kenneth P. Morgan, Julian P. Gunn, Robert F. Storey
Publikováno v:
Platelets, Vol 32, Iss 4, Pp 555-559 (2021)
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevati
Externí odkaz:
https://doaj.org/article/3333115ba44f4ecd927f58c21aa5c9b6
Autor:
Jiawen Li, Yulong Li, Shuhong Su, Zhifang Wang, Haiwei Liu, Weixian Yang, Shubin Qiao, Yuejin Yang, Bo Xu, Runlin Gao, Jinqing Yuan, Xueyan Zhao
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 8, p 218 (2023)
Background: Bivalirudin reduces ischemic and hemorrhagic events in patients undergoing primary percutaneous coronary intervention (PCI), but the safety and efficacy for such individuals are unclear. Our aim was to evaluate the long-term safety and ef
Externí odkaz:
https://doaj.org/article/4eb190aaea5b4895a3d0ea41844fd1f2
Autor:
Carolina Saleiro, Rogério Teixeira, Diana De Campos, João Lopes, Bárbara Oliveiros, Marco Costa, Lino Gonçalves
Publikováno v:
Journal of Intensive Care, Vol 8, Iss 1, Pp 1-12 (2020)
Abstract Background Cardiogenic shock complicates 5–10% of myocardial infarction (MI) cases. Data about the benefit of glycoprotein IIb/IIIa inhibitors (GPI) in these patients is sparse and conflicting. Methods We performed a systematic review, met
Externí odkaz:
https://doaj.org/article/9ad75e60ea77449580c4ed5d4680693c
Autor:
Dong Huang, Juying Qian, Zongjun Liu, Yawei Xu, Xianxian Zhao, Zengyong Qiao, Weiyi Fang, Li Jiang, Wei Hu, Chengxing Shen, Chun Liang, Qi Zhang, Junbo Ge
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: To determine whether intracoronary pro-urokinase or tirofiban improves myocardial reperfusion during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).Methods: The study included
Externí odkaz:
https://doaj.org/article/270837e311ab41549588e2fffbebe322